Vascular smooth muscle α(v)β3 integrin mediates arteriolar vasodilation in response to RGD peptides

Circulation Research

Volumn 79, Issue 4, 1996, Pages 821-826

  Mogford, Jon E ^a   Davis, George E ^b   Platts, Steven H ^a   Meininger, Gerald A ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Arg Gly Asp; collagen degradation; vascular wound response; vasodilation; (v) 3 integrin

Indexed keywords

INTEGRIN; SCLEROPROTEIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; COLLAGEN DEGRADATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 0029797941     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.4.821     Document Type: Article

References (31)

1. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992;69:11-25.
2. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365-400.
3. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science. 1995;268:233-239.
4. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 1984;309:30-33.
5. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem, 1988;57:375-413.
6. 1). J Biol Chem. 1990;265:5934-5937.
7. 5: an adhesion receptor for vitronectin. J Biol Chem. 1990;265:11008-11013.
8. Pytela R, Pierschbacher MD, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Science. 1986;231:1559-1562.
9. Hostikka SL, Tryggvason K. The complete primary structure of the α2 chain of human type IV collagen and comparison with the α1 (IV) chain. J Biol Chem. 1988;263:19488-19493.
10. Bernard MP, Myers JC, Chu ML, Ramirez F, Eikenberry EF, Prockop DJ. Structure of a cDNA for the proα2 chain of human type I procollagen: comparison with chick cDNA for proα2(I) identifies structurally conserved features of the protein and the gene. Biochemistry. 1983;22:1139-1145.
11. Pierschbacher MD, Ruoslahti E, Sundelin J, Lind P, Peterson PA. The cell attachment domain of fibronectin: determination of the primary structure. J Biol Chem. 1982;257:9593-9597.
12. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA: similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985;4:2519-2524.
13. 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun. 1992;182:1025-1031.
14. Pfaff M, Aumailley M, Specks U, Knolle J, Zerwes HG, Timpl R. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type IV. Exp Cell Res. 1993;206:167-176.
15. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A. 1994;91:8856-8860.
16. Falcone JC, Davis MJ, Meininger GA. Endothelial independence of myogenic response in isolated skeletal muscle arterioles. Am J Physiol. 1991;260:H130-H135.
17. Davis GE, Camarillo CW. Regulation of integrin-mediated myeloid cell adhesion to fibronectin: influence of disulfide reducing agents, divalent cations and phorbol ester. J Immunol. 1993;151:7138-7150.
18. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem. 1987;262:17294-17298.
19. Watorek W, Parley D, Salvesen G, Travis J. Neutrophil elastase and cathepsin G: structure, function, and biological control. Adv Exp Med Biol. 1988;240:23-31.
20. Treede RD, Meyer RA, Davis KD, Campbell JN. Intradermal injections of bradykinin or histamine cause a flare-like vasodilation in monkey: evidence from laser Doppler studies. Neurosci Lett. 1990;115:201-206.
21. Wei EP, Kontos HA, Dietrich WD, Povlishock JT, Ellis EF, Inhibition by free radical scavengers and by cyclooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury in cats. Circ Res. 1981;48:95-103.
22. Ingber DE. Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci. 1993;104:613-627.
23. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:2364-2372.
24. LaFlamme SE, Akiyama SK, Yamada KM. Regulation of fibronectin receptor distribution. J Cell Biol. 1992;117:437-447.
25. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science. 1995;67:883-885.
26. Lund T, Onarheim H, Wiig H, Reed RK. Mechanisms behind increased dermal imbibition pressure in acute burn edema. Am J Physiol. 1989;256:H940-H948.
27. Cleutjens JPM, Weber KT. Collagen degradation after myocardial infarction. In: Weber KT, ed. Wound Healing in Cardiovascular Disease. Armonk, NY: Futura Publishing; 1995:169-177.
28. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol. 1994;125:929-943.
29. Sueishi K, Nanno S, Tanaka K. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb Haemost. 1981;45:90-94.
30. Laskin DL, Kimura T, Sakakibara S, Riley DJ, Berg RA. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol. 1986;39:255-266.
31. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest. 1980;66:859-862.